IFP Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

IFP Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-119	Closed	-$9K	–	4260
2018 Q1	$9K	Hold	119	–	–	﹤0.01%	2886
2017 Q4	$9K	Buy	119 +8	+7%	+$665	﹤0.01%	2931
2017 Q3	$10K	Sell	111 -10	-8%	-$961	﹤0.01%	3064
2017 Q2	$14K	Buy	121 +111	+1,110%	+$12.4K	﹤0.01%	2832
2017 Q1	$1K	Buy	10 +4	+67%	+$427	﹤0.01%	3937
2016 Q4	$1K	Hold	6	–	–	﹤0.01%	3928
2016 Q3	$1K	Buy	+6	New	+$708	﹤0.01%	3849

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IFP Advisors's CBPO Position: Q2 2018 in Review

IFP Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 119 shares — an estimated $9K sold.

IFP Advisors first reported a position in CBPO in Q3 2016 and held it in 7 quarters. The position peaked at $14K in Q2 2017. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

IFP Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
IFP Advisors sold 119 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $9K.
IFP Advisors first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 7 quarters.
IFP Advisors's China Biologic Products Holdings, Inc. position peaked at $14K in Q2 2017.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.